Advertisement

Index by author

December 01, 1997; Volume 25,Issue 12

A

  1. Adkison, Kimberly K.

    1. Effects of Probenecid on Brain-Cerebrospinal Fluid-Blood Distribution Kinetics of E-Δ2-Valproic Acid in Rabbits
      Jamie L. Scism, Karen M. Powers, Alan A. Artru, Anne C. Chambers, Lydia Lewis, Kimberly K. Adkison, Thomas F. Kalhorn and Danny D. Shen
      Drug Metabolism and Disposition December 1997, 25 (12) 1337-1346;

  2. Alburges, Mario E.

    1. The Involvement of Cytochrome P450 3A4 in theN-Demethylation ofl-α-Acetylmethadol (LAAM), norLAAM, and Methadone
      David E. Moody, Mario E. Alburges, Robert J. Parker, Jerry M. Collins and John M. Strong
      Drug Metabolism and Disposition December 1997, 25 (12) 1347-1353;

  3. Arora, Sanjeev

    1. Human Lymphocyte Cytochrome P450 2E1, a Putative Marker for Alcohol-Mediated Changes in Hepatic Chlorzoxazone Activity
      Judy L. Raucy, Eric D. Schultz, Mike R. Wester, Sanjeev Arora, David E. Johnston, John L. Omdahl and Susan P. Carpenter
      Drug Metabolism and Disposition December 1997, 25 (12) 1429-1435;

  4. Artru, Alan A.

    1. Effects of Probenecid on Brain-Cerebrospinal Fluid-Blood Distribution Kinetics of E-Δ2-Valproic Acid in Rabbits
      Jamie L. Scism, Karen M. Powers, Alan A. Artru, Anne C. Chambers, Lydia Lewis, Kimberly K. Adkison, Thomas F. Kalhorn and Danny D. Shen
      Drug Metabolism and Disposition December 1997, 25 (12) 1337-1346;

B

  1. Bélanger, Alain

    1. Glucuronidation of Opioids, Carboxylic Acid-Containing Drugs, and Hydroxylated Xenobiotics Catalyzed by Expressed Monkey UDP-Glucuronosyltransferase 2B9 Protein
      Mitchell D. Green, Guy Bélanger, Dean W. Hum, Alain Bélanger and Thomas R. Tephly
      Drug Metabolism and Disposition December 1997, 25 (12) 1389-1394;

  2. Bélanger, Guy

    1. Glucuronidation of Opioids, Carboxylic Acid-Containing Drugs, and Hydroxylated Xenobiotics Catalyzed by Expressed Monkey UDP-Glucuronosyltransferase 2B9 Protein
      Mitchell D. Green, Guy Bélanger, Dean W. Hum, Alain Bélanger and Thomas R. Tephly
      Drug Metabolism and Disposition December 1997, 25 (12) 1389-1394;

C

  1. Carpenter, Susan P.

    1. Human Lymphocyte Cytochrome P450 2E1, a Putative Marker for Alcohol-Mediated Changes in Hepatic Chlorzoxazone Activity
      Judy L. Raucy, Eric D. Schultz, Mike R. Wester, Sanjeev Arora, David E. Johnston, John L. Omdahl and Susan P. Carpenter
      Drug Metabolism and Disposition December 1997, 25 (12) 1429-1435;

  2. Chambers, Anne C.

    1. Effects of Probenecid on Brain-Cerebrospinal Fluid-Blood Distribution Kinetics of E-Δ2-Valproic Acid in Rabbits
      Jamie L. Scism, Karen M. Powers, Alan A. Artru, Anne C. Chambers, Lydia Lewis, Kimberly K. Adkison, Thomas F. Kalhorn and Danny D. Shen
      Drug Metabolism and Disposition December 1997, 25 (12) 1337-1346;

  3. Choi, Sung Hee

    1. Gadolinium Chloride Inhibition of Rat Hepatic Microsomal Epoxide Hydrolase and Glutathione S-Transferase Gene Expression
      Sang Geon Kim and Sung Hee Choi
      Drug Metabolism and Disposition December 1997, 25 (12) 1416-1423;

  4. Christ, David D.

    1. In Vitro and In Vivo Effects of the Arylamine Human Immunodeficiency Virus Protease Inhibitor 4R-(4α,5α,6β,7β)-1-[(3-(1-Imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)methyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one (SD894) on Rat Hepatic Cytochrome P450 2B and 3A
      Mary F. Grubb, Sharon Diamond and David D. Christ
      Drug Metabolism and Disposition December 1997, 25 (12) 1424-1428;

  5. Clay, Michael P.

    1. In Vitro Biotransformation and Identification of Human Cytochrome P450 Isozyme-Dependent Metabolism of Tazofelone
      Sekhar S. Surapaneni, Michael P. Clay, Larry A. Spangle, Jonathan W. Paschal and Terry D. Lindstrom
      Drug Metabolism and Disposition December 1997, 25 (12) 1383-1388;

  6. Collins, Jerry M.

    1. The Involvement of Cytochrome P450 3A4 in theN-Demethylation ofl-α-Acetylmethadol (LAAM), norLAAM, and Methadone
      David E. Moody, Mario E. Alburges, Robert J. Parker, Jerry M. Collins and John M. Strong
      Drug Metabolism and Disposition December 1997, 25 (12) 1347-1353;

  7. Cui, Donghui

    1. Metabolism and Excretion of a New Antianxiety Drug Candidate, CP-93,393, in Cynomolgus Monkeys
      Chandra Prakash and Donghui Cui
      Drug Metabolism and Disposition December 1997, 25 (12) 1395-1406;

  8. Czira, Gábor

    1. Species Differences in Metabolism of Panomifene, an Analogue of Tamoxifen
      Katalin Monostory, Katalin Jemnitz, László Vereczkey and Gábor Czira
      Drug Metabolism and Disposition December 1997, 25 (12) 1370-1378;

D

  1. Diamond, Sharon

    1. In Vitro and In Vivo Effects of the Arylamine Human Immunodeficiency Virus Protease Inhibitor 4R-(4α,5α,6β,7β)-1-[(3-(1-Imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)methyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one (SD894) on Rat Hepatic Cytochrome P450 2B and 3A
      Mary F. Grubb, Sharon Diamond and David D. Christ
      Drug Metabolism and Disposition December 1997, 25 (12) 1424-1428;

  2. Dockham, Patricia A.

    1. Relative Contribution of Human Erythrocyte Aldehyde Dehydrogenase to the Systemic Detoxification of the Oxazaphosphorines
      Patricia A. Dockham, Lakshmaiah Sreerama and Norman E. Sladek
      Drug Metabolism and Disposition December 1997, 25 (12) 1436-1441;

G

  1. Green, Mitchell D.

    1. Glucuronidation of Opioids, Carboxylic Acid-Containing Drugs, and Hydroxylated Xenobiotics Catalyzed by Expressed Monkey UDP-Glucuronosyltransferase 2B9 Protein
      Mitchell D. Green, Guy Bélanger, Dean W. Hum, Alain Bélanger and Thomas R. Tephly
      Drug Metabolism and Disposition December 1997, 25 (12) 1389-1394;

  2. Grubb, Mary F.

    1. In Vitro and In Vivo Effects of the Arylamine Human Immunodeficiency Virus Protease Inhibitor 4R-(4α,5α,6β,7β)-1-[(3-(1-Imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)methyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one (SD894) on Rat Hepatic Cytochrome P450 2B and 3A
      Mary F. Grubb, Sharon Diamond and David D. Christ
      Drug Metabolism and Disposition December 1997, 25 (12) 1424-1428;

H

  1. Hum, Dean W.

    1. Glucuronidation of Opioids, Carboxylic Acid-Containing Drugs, and Hydroxylated Xenobiotics Catalyzed by Expressed Monkey UDP-Glucuronosyltransferase 2B9 Protein
      Mitchell D. Green, Guy Bélanger, Dean W. Hum, Alain Bélanger and Thomas R. Tephly
      Drug Metabolism and Disposition December 1997, 25 (12) 1389-1394;

I

  1. Imamura, Tohru

    1. Induction of Rat Hepatic Cytochrome P450 2B Subfamily by Azidophenobarbital, as a Possible Photoaffinity Probe for the Putative Phenobarbital Receptor
      Taishi Shinohara, Ken-ichiro Taura, Tohru Imamura, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition December 1997, 25 (12) 1442-1446;

J

  1. Jemnitz, Katalin

    1. Species Differences in Metabolism of Panomifene, an Analogue of Tamoxifen
      Katalin Monostory, Katalin Jemnitz, László Vereczkey and Gábor Czira
      Drug Metabolism and Disposition December 1997, 25 (12) 1370-1378;

  2. Johnston, David E.

    1. Human Lymphocyte Cytochrome P450 2E1, a Putative Marker for Alcohol-Mediated Changes in Hepatic Chlorzoxazone Activity
      Judy L. Raucy, Eric D. Schultz, Mike R. Wester, Sanjeev Arora, David E. Johnston, John L. Omdahl and Susan P. Carpenter
      Drug Metabolism and Disposition December 1997, 25 (12) 1429-1435;

K

  1. Kalhorn, Thomas F.

    1. Effects of Probenecid on Brain-Cerebrospinal Fluid-Blood Distribution Kinetics of E-Δ2-Valproic Acid in Rabbits
      Jamie L. Scism, Karen M. Powers, Alan A. Artru, Anne C. Chambers, Lydia Lewis, Kimberly K. Adkison, Thomas F. Kalhorn and Danny D. Shen
      Drug Metabolism and Disposition December 1997, 25 (12) 1337-1346;

  2. Kim, Sang Geon

    1. Gadolinium Chloride Inhibition of Rat Hepatic Microsomal Epoxide Hydrolase and Glutathione S-Transferase Gene Expression
      Sang Geon Kim and Sung Hee Choi
      Drug Metabolism and Disposition December 1997, 25 (12) 1416-1423;

  3. Koenigs, Luke L.

    1. Mechanism-Based Inactivation of Human Liver Cytochrome P450 2A6 by 8-Methoxypsoralen
      Luke L. Koenigs, Raimund M. Peter, Stella J. Thompson, Allan E. Rettie and William F. Trager
      Drug Metabolism and Disposition December 1997, 25 (12) 1407-1415;

  4. Kwan, K. C.

    1. Oral Bioavailability and First-Pass Effects
      K. C. Kwan
      Drug Metabolism and Disposition December 1997, 25 (12) 1329-1336;

L

  1. Lee, Sun H.

    1. Cytochrome P450 Isozymes Involved in Lisofylline Metabolism to Pentoxifylline in Human Liver Microsomes
      Sun H. Lee and John T. Slattery
      Drug Metabolism and Disposition December 1997, 25 (12) 1354-1358;

  2. Lewis, Lydia

    1. Effects of Probenecid on Brain-Cerebrospinal Fluid-Blood Distribution Kinetics of E-Δ2-Valproic Acid in Rabbits
      Jamie L. Scism, Karen M. Powers, Alan A. Artru, Anne C. Chambers, Lydia Lewis, Kimberly K. Adkison, Thomas F. Kalhorn and Danny D. Shen
      Drug Metabolism and Disposition December 1997, 25 (12) 1337-1346;

  3. Lindstrom, Terry D.

    1. In Vitro Biotransformation and Identification of Human Cytochrome P450 Isozyme-Dependent Metabolism of Tazofelone
      Sekhar S. Surapaneni, Michael P. Clay, Larry A. Spangle, Jonathan W. Paschal and Terry D. Lindstrom
      Drug Metabolism and Disposition December 1997, 25 (12) 1383-1388;

  4. Linnet, Kristian

    1. Metabolism of Clozapine by cDNA-Expressed Human Cytochrome P450 Enzymes
      Kristian Linnet and Ole V. Olesen
      Drug Metabolism and Disposition December 1997, 25 (12) 1379-1382;

M

  1. Monostory, Katalin

    1. Species Differences in Metabolism of Panomifene, an Analogue of Tamoxifen
      Katalin Monostory, Katalin Jemnitz, László Vereczkey and Gábor Czira
      Drug Metabolism and Disposition December 1997, 25 (12) 1370-1378;

  2. Moody, David E.

    1. The Involvement of Cytochrome P450 3A4 in theN-Demethylation ofl-α-Acetylmethadol (LAAM), norLAAM, and Methadone
      David E. Moody, Mario E. Alburges, Robert J. Parker, Jerry M. Collins and John M. Strong
      Drug Metabolism and Disposition December 1997, 25 (12) 1347-1353;

N

  1. Nau, Heinz

    1. 9,13-Dicis-Retinoic Acid as an Isomerization Product of 9-cis-Retinoic Acid  
      Jörn Oliver Sass, Georg Tzimas and Heinz Nau
      Drug Metabolism and Disposition December 1997, 25 (12) 1447;

O

  1. Obach, R. Scott

    1. Nonspecific Binding to Microsomes: Impact on Scale-Up of in Vitro Intrinsic Clearance to Hepatic Clearance as Assessed Through Examination of Warfarin, Imipramine, and Propranolol
      R. Scott Obach
      Drug Metabolism and Disposition December 1997, 25 (12) 1359-1369;

  2. Oguri, Kazuta

    1. Induction of Rat Hepatic Cytochrome P450 2B Subfamily by Azidophenobarbital, as a Possible Photoaffinity Probe for the Putative Phenobarbital Receptor
      Taishi Shinohara, Ken-ichiro Taura, Tohru Imamura, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition December 1997, 25 (12) 1442-1446;

  3. Olesen, Ole V.

    1. Metabolism of Clozapine by cDNA-Expressed Human Cytochrome P450 Enzymes
      Kristian Linnet and Ole V. Olesen
      Drug Metabolism and Disposition December 1997, 25 (12) 1379-1382;

  4. Omdahl, John L.

    1. Human Lymphocyte Cytochrome P450 2E1, a Putative Marker for Alcohol-Mediated Changes in Hepatic Chlorzoxazone Activity
      Judy L. Raucy, Eric D. Schultz, Mike R. Wester, Sanjeev Arora, David E. Johnston, John L. Omdahl and Susan P. Carpenter
      Drug Metabolism and Disposition December 1997, 25 (12) 1429-1435;

P

  1. Parker, Robert J.

    1. The Involvement of Cytochrome P450 3A4 in theN-Demethylation ofl-α-Acetylmethadol (LAAM), norLAAM, and Methadone
      David E. Moody, Mario E. Alburges, Robert J. Parker, Jerry M. Collins and John M. Strong
      Drug Metabolism and Disposition December 1997, 25 (12) 1347-1353;

  2. Paschal, Jonathan W.

    1. In Vitro Biotransformation and Identification of Human Cytochrome P450 Isozyme-Dependent Metabolism of Tazofelone
      Sekhar S. Surapaneni, Michael P. Clay, Larry A. Spangle, Jonathan W. Paschal and Terry D. Lindstrom
      Drug Metabolism and Disposition December 1997, 25 (12) 1383-1388;

  3. Peter, Raimund M.

    1. Mechanism-Based Inactivation of Human Liver Cytochrome P450 2A6 by 8-Methoxypsoralen
      Luke L. Koenigs, Raimund M. Peter, Stella J. Thompson, Allan E. Rettie and William F. Trager
      Drug Metabolism and Disposition December 1997, 25 (12) 1407-1415;

  4. Powers, Karen M.

    1. Effects of Probenecid on Brain-Cerebrospinal Fluid-Blood Distribution Kinetics of E-Δ2-Valproic Acid in Rabbits
      Jamie L. Scism, Karen M. Powers, Alan A. Artru, Anne C. Chambers, Lydia Lewis, Kimberly K. Adkison, Thomas F. Kalhorn and Danny D. Shen
      Drug Metabolism and Disposition December 1997, 25 (12) 1337-1346;

  5. Prakash, Chandra

    1. Metabolism and Excretion of a New Antianxiety Drug Candidate, CP-93,393, in Cynomolgus Monkeys
      Chandra Prakash and Donghui Cui
      Drug Metabolism and Disposition December 1997, 25 (12) 1395-1406;

R

  1. Raucy, Judy L.

    1. Human Lymphocyte Cytochrome P450 2E1, a Putative Marker for Alcohol-Mediated Changes in Hepatic Chlorzoxazone Activity
      Judy L. Raucy, Eric D. Schultz, Mike R. Wester, Sanjeev Arora, David E. Johnston, John L. Omdahl and Susan P. Carpenter
      Drug Metabolism and Disposition December 1997, 25 (12) 1429-1435;

  2. Rettie, Allan E.

    1. Mechanism-Based Inactivation of Human Liver Cytochrome P450 2A6 by 8-Methoxypsoralen
      Luke L. Koenigs, Raimund M. Peter, Stella J. Thompson, Allan E. Rettie and William F. Trager
      Drug Metabolism and Disposition December 1997, 25 (12) 1407-1415;

S

  1. Sass, Jörn Oliver

    1. 9,13-Dicis-Retinoic Acid as an Isomerization Product of 9-cis-Retinoic Acid  
      Jörn Oliver Sass, Georg Tzimas and Heinz Nau
      Drug Metabolism and Disposition December 1997, 25 (12) 1447;

  2. Schultz, Eric D.

    1. Human Lymphocyte Cytochrome P450 2E1, a Putative Marker for Alcohol-Mediated Changes in Hepatic Chlorzoxazone Activity
      Judy L. Raucy, Eric D. Schultz, Mike R. Wester, Sanjeev Arora, David E. Johnston, John L. Omdahl and Susan P. Carpenter
      Drug Metabolism and Disposition December 1997, 25 (12) 1429-1435;

  3. Scism, Jamie L.

    1. Effects of Probenecid on Brain-Cerebrospinal Fluid-Blood Distribution Kinetics of E-Δ2-Valproic Acid in Rabbits
      Jamie L. Scism, Karen M. Powers, Alan A. Artru, Anne C. Chambers, Lydia Lewis, Kimberly K. Adkison, Thomas F. Kalhorn and Danny D. Shen
      Drug Metabolism and Disposition December 1997, 25 (12) 1337-1346;

  4. Shen, Danny D.

    1. Effects of Probenecid on Brain-Cerebrospinal Fluid-Blood Distribution Kinetics of E-Δ2-Valproic Acid in Rabbits
      Jamie L. Scism, Karen M. Powers, Alan A. Artru, Anne C. Chambers, Lydia Lewis, Kimberly K. Adkison, Thomas F. Kalhorn and Danny D. Shen
      Drug Metabolism and Disposition December 1997, 25 (12) 1337-1346;

  5. Shinohara, Taishi

    1. Induction of Rat Hepatic Cytochrome P450 2B Subfamily by Azidophenobarbital, as a Possible Photoaffinity Probe for the Putative Phenobarbital Receptor
      Taishi Shinohara, Ken-ichiro Taura, Tohru Imamura, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition December 1997, 25 (12) 1442-1446;

  6. Sladek, Norman E.

    1. Relative Contribution of Human Erythrocyte Aldehyde Dehydrogenase to the Systemic Detoxification of the Oxazaphosphorines
      Patricia A. Dockham, Lakshmaiah Sreerama and Norman E. Sladek
      Drug Metabolism and Disposition December 1997, 25 (12) 1436-1441;

  7. Slattery, John T.

    1. Cytochrome P450 Isozymes Involved in Lisofylline Metabolism to Pentoxifylline in Human Liver Microsomes
      Sun H. Lee and John T. Slattery
      Drug Metabolism and Disposition December 1997, 25 (12) 1354-1358;

  8. Spangle, Larry A.

    1. In Vitro Biotransformation and Identification of Human Cytochrome P450 Isozyme-Dependent Metabolism of Tazofelone
      Sekhar S. Surapaneni, Michael P. Clay, Larry A. Spangle, Jonathan W. Paschal and Terry D. Lindstrom
      Drug Metabolism and Disposition December 1997, 25 (12) 1383-1388;

  9. Sreerama, Lakshmaiah

    1. Relative Contribution of Human Erythrocyte Aldehyde Dehydrogenase to the Systemic Detoxification of the Oxazaphosphorines
      Patricia A. Dockham, Lakshmaiah Sreerama and Norman E. Sladek
      Drug Metabolism and Disposition December 1997, 25 (12) 1436-1441;

  10. Strong, John M.

    1. The Involvement of Cytochrome P450 3A4 in theN-Demethylation ofl-α-Acetylmethadol (LAAM), norLAAM, and Methadone
      David E. Moody, Mario E. Alburges, Robert J. Parker, Jerry M. Collins and John M. Strong
      Drug Metabolism and Disposition December 1997, 25 (12) 1347-1353;

  11. Surapaneni, Sekhar S.

    1. In Vitro Biotransformation and Identification of Human Cytochrome P450 Isozyme-Dependent Metabolism of Tazofelone
      Sekhar S. Surapaneni, Michael P. Clay, Larry A. Spangle, Jonathan W. Paschal and Terry D. Lindstrom
      Drug Metabolism and Disposition December 1997, 25 (12) 1383-1388;

T

  1. Taura, Ken-ichiro

    1. Induction of Rat Hepatic Cytochrome P450 2B Subfamily by Azidophenobarbital, as a Possible Photoaffinity Probe for the Putative Phenobarbital Receptor
      Taishi Shinohara, Ken-ichiro Taura, Tohru Imamura, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition December 1997, 25 (12) 1442-1446;

  2. Tephly, Thomas R.

    1. Glucuronidation of Opioids, Carboxylic Acid-Containing Drugs, and Hydroxylated Xenobiotics Catalyzed by Expressed Monkey UDP-Glucuronosyltransferase 2B9 Protein
      Mitchell D. Green, Guy Bélanger, Dean W. Hum, Alain Bélanger and Thomas R. Tephly
      Drug Metabolism and Disposition December 1997, 25 (12) 1389-1394;

  3. Thompson, Stella J.

    1. Mechanism-Based Inactivation of Human Liver Cytochrome P450 2A6 by 8-Methoxypsoralen
      Luke L. Koenigs, Raimund M. Peter, Stella J. Thompson, Allan E. Rettie and William F. Trager
      Drug Metabolism and Disposition December 1997, 25 (12) 1407-1415;

  4. Trager, William F.

    1. Mechanism-Based Inactivation of Human Liver Cytochrome P450 2A6 by 8-Methoxypsoralen
      Luke L. Koenigs, Raimund M. Peter, Stella J. Thompson, Allan E. Rettie and William F. Trager
      Drug Metabolism and Disposition December 1997, 25 (12) 1407-1415;

  5. Tzimas, Georg

    1. 9,13-Dicis-Retinoic Acid as an Isomerization Product of 9-cis-Retinoic Acid  
      Jörn Oliver Sass, Georg Tzimas and Heinz Nau
      Drug Metabolism and Disposition December 1997, 25 (12) 1447;

V

  1. Vereczkey, László

    1. Species Differences in Metabolism of Panomifene, an Analogue of Tamoxifen
      Katalin Monostory, Katalin Jemnitz, László Vereczkey and Gábor Czira
      Drug Metabolism and Disposition December 1997, 25 (12) 1370-1378;

W

  1. Wester, Mike R.

    1. Human Lymphocyte Cytochrome P450 2E1, a Putative Marker for Alcohol-Mediated Changes in Hepatic Chlorzoxazone Activity
      Judy L. Raucy, Eric D. Schultz, Mike R. Wester, Sanjeev Arora, David E. Johnston, John L. Omdahl and Susan P. Carpenter
      Drug Metabolism and Disposition December 1997, 25 (12) 1429-1435;

Y

  1. Yamada, Hideyuki

    1. Induction of Rat Hepatic Cytochrome P450 2B Subfamily by Azidophenobarbital, as a Possible Photoaffinity Probe for the Putative Phenobarbital Receptor
      Taishi Shinohara, Ken-ichiro Taura, Tohru Imamura, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition December 1997, 25 (12) 1442-1446;
Back to top

In this issue

Drug Metabolism and Disposition
Vol. 25, Issue 12
1 Dec 1997
Sign up for alerts